Qsemble Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.4M Buy
69,862
+38,793
+125% +$3.39M 0.82% 22
2026
Q1
$2.65M Buy
+31,069
New +$2.77M 0.2% 168
2025
Q1
Sell
-28,824
Closed -$2.62M 452
2024
Q4
$2.62M Buy
+28,824
New +$2.75M 0.35% 108
2023
Q4
Sell
-48,000
Closed -$3.41M 369
2023
Q3
$3.41M Buy
+48,000
New +$3.59M 0.64% 55
2023
Q2
Sell
-18,300
Closed -$1.38M 231
2023
Q1
$1.38M Sell
18,300
-2,400
-12% -$178K 0.93% 24
2022
Q4
$1.63M Buy
+20,700
New +$1.55M 1.13% 17

Other funds holding CL

Qsemble Capital Management's CL Position: Q2 2026 in Review

Qsemble Capital Management increased its Colgate-Palmolive (CL) stake by 125% in Q2 2026, buying an estimated $3.39M and bringing the position to 69,862 shares worth $6.4M. The position accounts for 0.82% of the portfolio, ranked #22.

Qsemble Capital Management first reported a position in CL in Q4 2022 and has held it in 6 quarters since. 2,015 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Qsemble Capital Management held 69,862 shares of Colgate-Palmolive worth $6.4M as of Q2 2026.
  • Qsemble Capital Management bought 38,793 Colgate-Palmolive shares in Q2 2026, an estimated $3.39M.
  • Colgate-Palmolive made up 0.82% of Qsemble Capital Management's portfolio in Q2 2026, its #22 holding.
  • Qsemble Capital Management first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 6 quarters since.
  • 2,015 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.